possess biological and physicochemical properties which differ from those of all other known animal viruses. Among these unique properties are the ability of the agents to produce fatal neurological disease without eliciting inflammation or provoking humoral or cell-mediated immune response, and the resistance of these agents to heat, radiating energy, formalin, and most products used for decontamination in patient care areas and hospital laboratories. CJD is a rare disorder, with an incidence of approximately one case per million persons per year. Despite a familial incidence of 15-20%, conjugal cases of the disease are extremely rare, and only a handful of cases have been described in physicians or other health care workers. No case has been reported in pathologists -the group of physicians most likely to be exposed to infected organs -or in research workers who handle clinical or experimental material. Nevertheless, the
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inexorably progressive nature of the disease, the lack of vaccine or treatment, and the extreme resistance of the agent of CJD to conventional methods of decontamination have raised great concern about precautions for dealing with CJD-infected material and have, at times, caused CJD patients to be approached with a degree of caution not far removed from abject fear.
The present issue of Infection Control contains recommendations offered by the Centers for Disease Control for containment and decontamination methods in diagnosed or suspected cases of CJD. These recommendations are based on careful review of the existing literature and provide useful guidelines for the care of CJD patients. It should be kept in mind that the precautions listed for surgical procedures, in particular craniotomy, are based on the documented transmission of CJD by contaminated instruments during surgery. The warnings against using as organ donors patients with unexplained dementia are likewise based on clinical experience " and, indeed, recent cases in which rabies has also been transmitted by corneal transplantation 4 " 6 suggest that no patient with an unexplained, possibly infectious neurological illness should be considered as a donor for corneal or organ transplant. It should also be remembered, however, that human-to-human transmission of CJD under conditions other than surgery on the brain or its extension, the eye, has never been documented. The threat posed by CJD patients to those involved in their medical or nursing care would appear to be extremely small or perhaps even nonexistent. The recommended precautions for dealing with CJD patients in nonsurgical conditions are based on estimated possibility of risk and not on actual clinical occurrence. There remains a great deal to be learned about the epidemiology and transmission of CJD, and optimal containment measures will not be developed until three major problems have been addressed. The first major problem in designing optimal containment methods in cases of CJD is that very little knowledge exists about the natural history of infection. The route of transmission of the disease has not been determined, nor has the risk of transcutaneous infection been defined in man. Without this information, containment measures must be imprecise and perhaps unnecessarily rigorous. Similarly, because CJD does not elicit a humoral or cell-mediated immune response, it has not been possible to study the distribution of the agent in human populations. Thus, it is not known whether infection with the agent of CJD invariably produces fatal neurological illness or whether CJD is a rare clinical manifestation of a much more common, usually inapparent infection. It is not known whether the likelihood
illness with a prevalence of one per million per year could be maintained without the occurrence of subclinical infection or the persistence of the agent in some n o n h u m a n reservoir. Ultimately, precautions for h a n d l i n g CJD-infected clinical and experimental material must be based on an understanding of the risk of a c q u i r i n g infection as well as the risk of a c q u i r i n g the disease itself, for these two risks may be of very different magnitude.
T h e second major problem involved in the care of patients with C J D concerns the sensitivity of the agent to physical and chemical methods of decontamination. A l t h o u g h a n u m b e r of papers have been published listing precautions for the care of C J D patients and for the h a n d l i n g of CJD-infected clinical and pathological materials, these recommendations are based on a small n u m b e r of studies dealing with mouse-adapted scrapie. Similarly published data do not exist for the agent of C J D . In part, the lack of information reflects the fact that, for many years, studies involving C J D were conducted in primates, with lengthy incubation periods and at great expense. More recently, however, the agent of C J D has been adapted to hamsters, rats and mice. These newer, less costly animal models of C J D should allow detailed investigations into the sensitivity of the agent to a variety of disinfectants under conditions similar to those encountered in patient care and autopsy situations. T h e concern and uncertainty engendered by C J D patients in most hospitals make such studies very important.
T h e third -and in many ways most difficult -problem in developing c o n t a i n m e n t measures for CJD-infected patients and materials involves the incorporation of these measures into n o r m a l hospital or n u r s i n g h o m e routine. Presently, recommended precautions for C J D cases are unlike those for any other infectious h u m a n condition likely to be encountered in clinical practice or at autopsy. Hospitals and n u r s i n g homes may, by dint of special efforts, apply these precautions in specific cases, but the complexity of these measures makes their use unlikely unless the diagnosis of C J D is virtually certain. Some hospitals and n u r s i n g homes may attempt to deal with this problem by simply refusing to accept C J D patients. Unfortunately, patients with C J D are not always easy to identify, a n d it is likely that many cases of the disease are never recognized and are labelled only as " d e m e n t i a . " Furthermore, the characteristic myoclonus and electroencephalographic changes are frequently absent early in the course of the disease and may disappear once the disease is far advanced, so that even where C J D is eventually suspected, the diagnosis may be made only after repeated neurological and encephalographic examinations or by examination of paraffin sections after autopsy. CJD, then, must remain a diagnostic possibility in every patient with rapidly progressive, unexplained dementia. In addition, the fact that C J D is a systemic infection would suggest that precautions appropriate for C J D should be considered not only in the patient w h o presents with failing intellect and myoclonus but also in the patient with dementia of u n k n o w n duration and course transferred from nursing h o m e or state hospital for surgical procedures such as transurethral prostatic resection or repair of h i p fracture, for treatment of medical conditions, or for autopsy. Until precautions for C J Dinfected material, such as those published in this journal, can be instituted as a routine, rational part of hospital, n u r s i n g home, and autopsy practice, diagnosed cases of C J D will continue to cause extraordinary disruption of normal patient care, while, in the undiagnosed case, unnecessary exposure of health care a n d laboratory workers to the agent of C J D -however slight the risk -will continue to occur.
